Correlation of sole prenatal indication to fetal chromosomal karyotype abnormality
Ying Xu, Fenfen Guo, Li J. Yu, Xu Hui, Tingting Song, Jiao Zheng, Biliang Chen, Jianfang Zhang
Abstract
Ying Xu, Fenfen Guo, Li J. Yu, Xu Hui, Tingting Song, Jiao Zheng, Biliang Chen, Jianfang Zhang
Abstract
Objective To analysis the clinical high risk factors for fetal chromosomal abnormalities. Methods Amniocentesis, chromosomal karyotype analysis and other related methods were performed on 4829 pregnant women, who presented sole indication of prenatal diagnosis such as advanced age, high risk factors and fetal ultrasound abnormalities, for analyzing the correlations of those women to the incidence of fetal chromosomal abnormalities. Results The detection rates of abnormal karyotype were 5.0% (57/1143), 1.7% (40/2367) and 4.3% (57/1319) in the older women group (age>35), abnormal maternal serological screening group and abnormal fetal ultrasound finding group, respectively. The detection rats of karyotype abnormality were 6.9% (23/333) in women with fetal congenital heart diseases, 8.5% (20/234) in those with abnormal amniotic fluid, 1.1% (1/89) in those with fetal ventriculomegaly, 1.1% (10/898) in those with fetal intracardiac hyperechogenicity, 5.9% (2/34) in those with fetal choroid cyst and 5.6% (1/18) in those with fetal renal pelvis broadening. Conclusion The pregnant women with age>35, fetal sonographic structural anomalies or two or more soft marker abnormalities should be prenatally diagnosed and doing the genetic counseling combined with the family history. DOI: 10.11855/j.issn.0577-7402.2017.02.14
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To analysis the clinical high risk factors for fetal chromosomal abnormalities. Methods Amniocentesis, chromosomal karyotype analysis and other related methods were performed on 4829 pregnant women, who presented sole indication of prenatal diagnosis such as advanced age, high risk factors and fetal ultrasound abnormalities, for analyzing the correlations of those women to the incidence of fetal chromosomal abnormalities. Results The detection rates of abnormal karyotype were 5.0% (57/1143), 1.7% (40/2367) and 4.3% (57/1319) in the older women group (age>35), abnormal maternal serological screening group and abnormal fetal ultrasound finding group, respectively. The detection rats of karyotype abnormality were 6.9% (23/333) in women with fetal congenital heart diseases, 8.5% (20/234) in those with abnormal amniotic fluid, 1.1% (1/89) in those with fetal ventriculomegaly, 1.1% (10/898) in those with fetal intracardiac hyperechogenicity, 5.9% (2/34) in those with fetal choroid cyst and 5.6% (1/18) in those with fetal renal pelvis broadening. Conclusion The pregnant women with age>35, fetal sonographic structural anomalies or two or more soft marker abnormalities should be prenatally diagnosed and doing the genetic counseling combined with the family history. DOI: 10.11855/j.issn.0577-7402.2017.02.14
Key concepts: Fetus, Amniocentesis, Medicine, Obstetrics, Prenatal diagnosis, Karyotype, Abnormality, Genetic counseling